• musoro_banner_01

Tirzepatide Lyophilized High Purity 99% Peptide Powder 60mg per vial yechirwere cheshuga uye kuora muviri.

Tsanangudzo Pfupi

Zita: Tirzepatide Injection Powder

Kuchena: 99%

Benefits: Kurapa Chirwere cheshuga, Kuonda

Kutonga: Subcutaneous Injection

Saizi: 10mg, 15mg, 20mg, 30mg, 60mg

Kuonekwa: White Lyophilized Powder


Product Detail

Product Tags

Product Detail

Zita Tirzepatide Jekiseni Poda
Kuchena 99%
Chitarisiko White Lyophilized Powder
Administration Subcutaneous Injection
Size 10mg, 15mg, 20mg, 30mg, 60mg
Mvura 3.0%
Benefits Kurapa Chirwere cheshuga, Kuderedza Uremu

Tsanangudzo

Tirzepatide Lyophilized Powder (60 mg)

Tirzepatide (LY3298176) ndiyo yekutanga mbiri-acting agonist inotarisa zvose GIP (glucose-dependent insulinotropic polypeptide) uye GLP-1 (glucagon-like peptide-1) receptors. Yakagamuchira kubvumidzwa kweUS FDA muna Chivabvu 2022 kurapwa kwerudzi rwechipiri chirwere cheshuga mellitus (T2DM) sechinhu chinopindirana nekudya uye maekisesaizi.
Ichi chigadzirwa chinopihwa se60mg lyophilized (yakaomeswa-yakaomeswa) isina kuomeswa poda mumidziyo, iyo inofanirwa kuvandudzwa nemvura ine bacteriostatic isati yaitwa. Kana ichienzaniswa neiyo imwe chete GLP-1 receptor agonists semaglutide kana dulaglutide, tirzepatide inoratidza hukuru hwepamusoro mukuvandudza kurongeka kweglucose yeropa, kuwedzera insulin senitivity, uye kutsigira uremu hwakakura. Aya mabhenefiti anoverengerwa kune ayo maviri-receptor synergistic maitiro ekuita.

Key Benefits
Glycemic Control

  • Inomutsa insulin secretion nenzira inoenderana neglucose
  • Inoderedza glucagon secretion, inonyatso kudzikisa mazinga eglucose weropa
  • Inotevedzera iyo yakasanganiswa metabolic mhedzisiro yeese GIP uye GLP-1

Weight Management

  • Inosimudzira satiety uye inoderedza caloric kudya
  • Yakaratidza yakakura uye yakaramba ichirasikirwa uremu muzvidzidzo zvekiriniki

Utano Hwomwoyo

  • Yekutanga data inoratidza inogona kudzikisa njodzi yemoyo muvarwere vane T2DM

Kushandisa uye Dosage

  • Tirzepatide lyophilized powder (60 mg) inofanira kugadziriswa nemvura ine bacteriostatic isati yashandiswa. Kutonga kunoitwa nejekiseni repasi, kazhinji kamwechete pasvondo pazuva rimwechete svondo rega rega.

Type 2 Chirwere cheshuga

  • Kutanga Dose: 2.5 mg kamwe pavhiki
  • Titration: Wedzera mavhiki ega ega e4 sekubvumidzwa
  • (→ 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg → 20 mg → 30 mg → 45 mg → kusvika 60 mg)
  • Common Dose: 10-30 mg vhiki nevhiki
  • Maximum Dose: 60 mg vhiki nevhiki

Kufutisa / Weight Management

  • Kutanga Dose: 2.5 mg kamwe pavhiki
  • Titration: Zvishoma nezvishoma kuwedzera kwedosi sekubvumidzwa
  • (2.5 → 5 → 7.5 → 10 → 12.5 → 15 → 20 → 30 → 45 → 60 mg)
  • Common Dose: 30-60 mg vhiki nevhiki
  • Maximum Dose: 60 mg vhiki nevhiki

Yakakurudzirwa Dosage Kuenzanisa

Indication Kutanga Dose Titration Chirongwa Common Dose Maximum Dose Frequency
Type 2 Chirwere cheshuga 2.5 mg vhiki nevhiki Wedzera mavhiki mana ega ega (→ 5 → 7.5 → 10 → 12.5 → 15 → 20 → 30 → 45 → 60) 10-30 mg vhiki nevhiki 60 mg vhiki nevhiki Kamwe pavhiki
Kufutisa / Kuderedza uremu 2.5 mg vhiki nevhiki Kuwedzera kunoenderana nekushivirira (2.5 → 5 → 7.5 → 10 → 12.5 → 15 → 20 → 30 → 45 → 60) 30-60 mg vhiki nevhiki 60 mg vhiki nevhiki Kamwe pavhiki

Cherechedza:Ita shuwa kuti imwe neimwe yapfuura dose inobvumirwa zvakanaka isati yakwira.

Zvingangoitika Zvakaipa

  • Gastrointestinal: Nausea, kurutsa, manyoka, uye kusagadzikana mudumbu (kazhinji panguva yekutanga)
  • Hypoglycemia: Kazhinji njodzi yakaderera, asi inowedzera kana yasanganiswa nemimwe mishonga yeantidiabetic
  • Injection Site Reactions: Kutsvuka, kukwenya, kuzvimba, kana kurwadziwa kwakadzika panzvimbo
  • Pancreatitis: Kashoma asi zvinogoneka; tarisisa marwadzo emudumbu anoramba aripo
  • Renal Effects: Kutariswa kwebasa reitsvo kunogona kudikanwa mune vamwe vanhu

Pharmacokinetics

  • Hafu-Hupenyu: Inenge 1 vhiki
  • Dosing Frequency: Inotsigira zviri nyore kamwechete-vhiki nevhiki kutonga

Summary
Tirzepatide 60 mg lyophilized poda inomiririra chizvarwa chinotevera chekurapa kufambira mberi, kusanganisa ine simba glycemic control nehuremu hunoshamisa hunoshanda uye inogona kudzivirira yemoyo.
Iine zvishoma nezvishoma titration purogiramu (2.5 mg → kusvika ku60 mg), inobvumira kuwedzerwa kushivirira uye kushanduka kwekurapa kwega. Kutonga kwayo kamwe-vhiki nevhiki kunonatsiridza kutevedzera, zvichiita kuti ive sarudzo itsva uye inoshanda kune manejimendi yerudzi rwechipiri chirwere cheshuga uye kufutisa mumakiriniki epamusoro uye ekutsvaga.


  • Zvakapfuura:
  • Zvinotevera:

  • Nyora meseji yako pano ugotitumira